Regulatory

Jul 20, 2016
Not yet, says Reflector. But to judge from the European Parliament's latest foray into the subject, there could be plenty of support for such an approach.
Jul 12, 2016
Pharmaceutical Executive
A look at how Europe’s new accelerated drug approval scheme can move existing review pathways to something better—and take a page from the FDA experience as well.
Jul 07, 2016
The long planned for transparency of industry payments to doctors, pharmacists, nurses and others has shone some dappled light on the UK industry, writes Leela Barham.
Jul 06, 2016
It's time for new pharma strategies to combat deadly drug-resistant infections, writes Jil Wechsler.
Jul 05, 2016
The UK's Brexit vote has unleashed turbulence in Europe — not least on its pharma sector. Reflector reports.
Jul 01, 2016
Leela Barham looks at the implications for the UK industry in the aftermath of last week's vote for Brexit.
Jun 30, 2016
FDA's Brenda Stodart outlines the services of the Agency's Small Business and Industry Assistance (SBIA) Program.
Jun 22, 2016
Highly skilled pharma staff are spending too much time on the routine updating of product information. Technology can free them, writes Dr. Jutta Hohenhörst.
Jun 21, 2016
Rapid growth in Medicare spending on prescription drugs is prompting a leading advisory group to recommend significant revisions in how the government pays for medicines under Part D and Part B
Jun 15, 2016
Despite enthusiasm from payers and pharma companies for innovative drug reimbursement strategies linked to positive patient responses, negotiating such deals is no easy business.
native1_300x100
lorem ipsum